Latest / tv.qiagenbioinformatics.com
‘Omics to Insights: Leveraging QIAGEN IPA for Pre-Clinical Toxicology and...
Pre-clinical toxicology studies generate complex datasets that require robust interpretation to identify potential safety liabilities early in drug development. QIAGEN Ingenuity Pathway Analysis (IPA) can help uncover mechanistic insights, predict toxicity outcomes and support decision-making in pre-clinical safety assessments. Explore how you can apply IPA to ‘omics data to identify toxicity signatures, understand mode of action (MoA) and prioritize biomarkers.
· Overview of QIAGEN Ingenuity Pathway Analysis
· Find transcriptomic and proteomic data from pre-clinical and clinical studies and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.